Loading…
DAWNZERA is a treatment for hereditary angioedema (HAE) that helps patients manage their condition. The product is supported by the Ionis Every Step program, which provides resources and assistance for starting or switching to the medication.
AI named Dawnzera from October 2025 to March 2026.